October 15, 2020
Orexo and Lyfebulb Announce the Winner of the 2020 Innovation Challenge in Substance Use Disorders
Media
October 14, 2020
Aprea Therapeutics Launches Disease Awareness Website for Healthcare Professionals, p53reactivation.com
October 14, 2020
GenSight Biologics Appoints Elsy Boglioli to its Board of Directors
October 14, 2020
Targovax ASA – successfully completed private placement
October 14, 2020
Spruce Biosciences Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
October 14, 2020
Oncopeptides signs € 40 million loan agreement with the EIB
October 13, 2020
Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer
October 12, 2020
Priothera closes €30 million Series A financing to develop highly promising therapies for acute myeloid leukemia (AML)
October 12, 2020
With the priority review underway at FDA, Oncopeptides moves forward with intent to file for conditional approval of melflufen with EMA
October 12, 2020
Targovax granted European Patent for ONCOS-102 in combination with checkpoint inhibitors
